CXCL5 activates CXCR2 in nociceptive sensory neurons to drive joint pain and inflammation in experimental gouty arthritis

Chengyu Yin,Boyu Liu,Zishan Dong,Sai Shi,Chenxing Peng,Yushuang Pan,Xiaochen Bi,Huimin Nie,Yunwen Zhang,Yan Tai,Qimiao Hu,Xuan Wang,Xiaomei Shao,Hailong An,Jianqiao Fang,Chuan Wang,Boyi Liu

DOI: https://doi.org/10.1038/s41467-024-47640-7

IF: 16.6

2024-04-16

Nature Communications

Abstract:Abstract Gouty arthritis evokes joint pain and inflammation. Mechanisms driving gout pain and inflammation remain incompletely understood. Here we show that CXCL5 activates CXCR2 expressed on nociceptive sensory neurons to drive gout pain and inflammation. CXCL5 expression was increased in ankle joints of gout arthritis model mice, whereas CXCR2 showed expression in joint-innervating sensory neurons. CXCL5 activates CXCR2 expressed on nociceptive sensory neurons to trigger TRPA1 activation, resulting in hyperexcitability and pain. Neuronal CXCR2 coordinates with neutrophilic CXCR2 to contribute to CXCL5-induced neutrophil chemotaxis via triggering CGRP- and substance P-mediated vasodilation and plasma extravasation. Neuronal Cxcr2 deletion ameliorates joint pain, neutrophil infiltration and gait impairment in model mice. We confirmed CXCR2 expression in human dorsal root ganglion neurons and CXCL5 level upregulation in serum from male patients with gouty arthritis. Our study demonstrates CXCL5-neuronal CXCR2-TRPA1 axis contributes to gouty arthritis pain, neutrophil influx and inflammation that expands our knowledge of immunomodulation capability of nociceptive sensory neurons.

multidisciplinary sciences

What problem does this paper attempt to address?

The problem this paper attempts to address is: elucidating the specific mechanisms by which CXCL5 drives joint pain and inflammation in gouty arthritis through the activation of CXCR2 receptors on sensory neurons. Specifically, the researchers found: 1. **Increased CXCL5 expression**: In a mouse model of gouty arthritis, the expression of CXCL5 in the ankle joint was significantly increased. 2. **CXCR2 expression on sensory neurons**: CXCR2 is expressed on sensory neurons, particularly those responsible for nociception (nociceptive sensory neurons). 3. **CXCL5 activates CXCR2**: CXCL5 triggers the activation of TRPA1 channels by activating CXCR2, leading to membrane depolarization and high excitability of neurons, thereby causing pain. 4. **Coordination between neuronal CXCR2 and neutrophil CXCR2**: CXCR2 on neurons works in coordination with CXCR2 on neutrophils, promoting CXCL5-induced neutrophil chemotaxis through CGRP and substance P-mediated vasodilation and plasma extravasation. 5. **Gene knockout experiments**: Specific knockout of Cxcr2 in sensory neurons significantly alleviated joint pain, neutrophil infiltration, and gait disturbances in the model mice. 6. **Human sample validation**: The researchers confirmed the expression of CXCR2 in human dorsal root ganglion (DRG) neurons and detected elevated levels of CXCL5 in the serum of gouty arthritis patients, which positively correlated with serum uric acid levels. In summary, this study reveals that CXCL5 drives the pain and inflammation mechanisms of gouty arthritis by activating CXCR2 receptors on sensory neurons, which in turn activates TRPA1 channels. This finding provides a new potential target for the treatment of gouty arthritis.

CXCL5 activates CXCR2 in nociceptive sensory neurons to drive joint pain and inflammation in experimental gouty arthritis

Nerve modulation therapy in gouty arthritis: targeting increased sFRP2 expression in dorsal root ganglion regulates macrophage polarization and alleviates endothelial damage

VGLUT2/ Cdk5/p25 Signaling Pathway Contributed to Inflammatory Pain By CFA

Mechanosensitive TRPV4 is required for crystal-induced inflammation

Cx3cl1/Cx3cr1 Regulates Nerve Injury-Induced Pain Hypersensitivity Through The Erk5 Signaling Pathway

Transmembrane TNF‐α is Sufficient for Articular Inflammation and Hypernociception in a Mouse Model of Gout

VGLUT2/Cdk5/p25 Signaling Pathway Contributed to Inflammatory Pain by Complete Freund’s Adjuvant

CXCL13 contributes to chronic pain of a mouse model of CRPS-I via CXCR5-mediated NF-κB activation and pro-inflammatory cytokine production in spinal cord dorsal horn

Connexin-43 Induces Chemokine Release from Spinal Cord Astrocytes to Maintain Late-Phase Neuropathic Pain in Mice

Dorsal Root Ganglion Neuron-Derived Sfrp2 Promotes Macrophage Polarization to Regulate Gouty Arthritis

Mice Overexpressing Chemokine Ligand 2 (CCL2) in Astrocytes Display Enhanced Nociceptive Responses

Peripheral CCL2 induces inflammatory pain via regulation of Ih currents in small diameter DRG neurons

Elevated plasma CXCL12 leads to pain chronicity via positive feedback upregulation of CXCL12/CXCR4 axis in pain synapses

NLRP3 inflammasome-mediated neutrophil recruitment and hypernociception depend on leukotriene B(4) in a murine model of gout.

CXCR3 signalling partially contributes to the pathogenesis of neuropathic pain in male rodents

CC Chemokine Ligand 2 (CCL2) Enhances TTX-sensitive Sodium Channel Activity of Primary Afferent Neurons in the Complete Freud Adjuvant-Induced Inflammatory Pain Model

Angiotensin II type 2 receptor pharmacological agonist, C21, reduces the inflammation and pain hypersensitivity in mice with joint inflammatory pain

Chemokine CCL2 and its receptor CCR2 in the medullary dorsal horn are involved in trigeminal neuropathic pain

Spinal CCL2 Promotes Pain Sensitization by Rapid Enhancement of NMDA-Induced Currents Through the ERK-GluN2B Pathway in Mouse Lamina II Neurons

Nlrp3 Inflammasome-Mediated Neutrophil Recruitment And Hypernociception Depends On Leukotriene B4 In A Murine Model Of Gout

Type II collagen facilitates gouty arthritis by regulating MSU crystallisation and inflammatory cell recruitment